Immune-mediated demyelinationHARTUNG, H.-P.Annals of neurology. 1993, Vol 33, Num 6, pp 563-567, issn 0364-5134Article

Acetyl glyceryl ether phosphorylcholine (platelet-activating factor) mediates heightened metabolic activity in macrophages: studies on PGE, TXB₂ and O₂^- production, spreading, and the influence of calmodulin-inhibitor W-7HARTUNG, H.-P.FEBS letters. 1983, Vol 160, Num 1-2, pp 209-212, issn 0014-5793Article

Molecular mechanisms of microglial activationZIELASEK, J; HARTUNG, H.-P.Advances in neuroimmunology. 1996, Vol 6, Num 2, pp 191-222, issn 0960-5428Article

Interferon-β zur Behandlung der schubförmig verlaufenden Multiplen Sklerose = Interferon-β treatment of relapsing-remitting multiple sclerosisHARTUNG, H.-P; HOHLFELD, R.Nervenarzt. 1994, Vol 65, Num 2, pp 139-145, issn 0028-2804Article

Neurologische Aspekte systemisch-rheumatischer Erkrankungen = Neurological aspects of systemic rheumatological disordersNEUHAUS, O; HARTUNG, H.-P.Zeitschrift für Rheumatologie (Print). 2004, Vol 63, Num 2, pp 104-112, issn 0340-1855, 9 p.Article

Synthesis of complement by macrophages and modulation of their functions through complement activationHARTUNG, H. P; HADDING, U.Springer seminars in immunopathology. 1983, Vol 6, Num 4, pp 283-326, issn 0344-4325Article

Pathogenetic role of autoantibodies in neurological diseasesARCHELOS, J. J; HARTUNG, H.-P.Trends in neurosciences (Regular edition). 2000, Vol 23, Num 7, pp 317-327, issn 0166-2236Article

Leukotriene production by cultured astroglial cellsHARTUNG, H.-P; TOYKA, K. V.Brain research. 1987, Vol 435, Num 1-2, pp 367-370, issn 0006-8993Article

Peripheral facial palsy : Etiology, diagnosis and treatmentROOB, G; FAZEKAS, F; HARTUNG, H.-P et al.European neurology. 1999, Vol 41, Num 1, pp 3-9, issn 0014-3022Article

Power spectrum analysis of heart rate variability in Guillain-Barré syndrome : A longitudinal studyFLACHENECKER, P; HARTUNG, H.-P; REINERS, K et al.Brain. 1997, Vol 120, pp 1885-1894, issn 0006-8950, 10Article

Soluble complement receptor type 1 inhibits experimental autoimmune neuritis in Lewis ratsJUNG, S; TOYKA, K. V; HARTUNG, H.-P et al.Neuroscience letters. 1995, Vol 200, Num 3, pp 167-170, issn 0304-3940Article

Primary rat astroglial cultures can generate leukotriene B₄HARTUNG, H.-P; HEININGER, K; TOYKA, K. V et al.Journal of neuroimmunology. 1988, Vol 19, Num 3, pp 237-243, issn 0165-5728Article

Chemically modified low density lipoproteins as inducers of enzyme release from macrophagesHARTUNG, H.-P; KLADETZKY, R. G; HENNERICI, M et al.FEBS letters. 1985, Vol 186, Num 2, pp 211-214, issn 0014-5793Article

Use of interferon beta in multiple sclerosis: rationale for early treatment and evidence for dose- and frequency-dependent effects on clinical responseCOYLE, P. K; HARTUNG, H-P.Multiple sclerosis. 2002, Vol 8, Num 1, pp 2-9, issn 1352-4585Article

Attenuation of experimental autoimmune neuritis in the Lewis rat by treatment with an antibody to L-selectinARCHELOS, J. J; FORTWÄNGLER, T; HARTUNG, H.-P et al.Neuroscience letters. 1997, Vol 235, Num 1-2, pp 9-12, issn 0304-3940Article

What is the role of ancillary investigations in establishing the diagnosis of multiple sclerosis?FAZEKAS, F; OFFENBACHER, H; HARTUNG, H.-P et al.European neurology. 1997, Vol 38, Num 4, pp 255-257, issn 0014-3022Article

Intravenous immunoglobulins in the treatment of relapsing remitting multiple sclerosis : results of a retrospective multicenter observational study over five yearsHAAS, I; MAAS-ENRIQUEZ, M; HARTUNG, H.-P et al.Multiple sclerosis. 2005, Vol 11, Num 5, pp 562-567, issn 1352-4585, 6 p.Article

T-cell apoptosis in autoimmune diseases : Termination of inflammation in the nervous system and other sites with specialized immune-defense mechanismsGOLD, R; HARTUNG, H.-P; LASSMANN, H et al.Trends in neurosciences (Regular edition). 1997, Vol 20, Num 9, pp 399-404, issn 0166-2236Article

T cell directed immunotherapy of inflammatory demyelination in the peripheral nervous system : Potent suppression of the effector phase of experimental autoimmune neuritis by anti-CD2 antibodiesJUNG, S; TOYKA, K; HARTUNG, H.-P et al.Brain. 1996, Vol 119, pp 1079-1090, issn 0006-8950, 4Article

Impact of 15-deoxyspergualin on effector cells in experimental autoimmune diseases of the nervous system in the Lewis ratJUNG, S; TOYKA, K. V; HARTUNG, H.-P et al.Clinical and experimental immunology (Print). 1994, Vol 98, Num 3, pp 494-502, issn 0009-9104Article

T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barré syndromeHARTUNG, H.-P; TOYKA, K. V.Annals of neurology. 1990, Vol 27, pp S57-S63, issn 0364-5134, supplConference Paper

Phorbol diester TPA elicits prostaglandin E release from cultured rat astrocytesHARTUNG, H.-P; TOYKA, K. V.Brain research. 1987, Vol 417, Num 2, pp 347-349, issn 0006-8993Article

Cellular activation: biochemistry and immunoregulation/5th. European workshop on inflammation, Cologne, 1st.-2nd. March, 1983PARNHAM, M. J; WINKELMANN, J; HARTUNG, H.-P et al.Collection sécurité. 1984, Vol 15, Num 1-2, pp 1-110, issn 0538-4818Conference Proceedings

Cloning and expression of the Campylobacter jejuni ion gene detected by RNA arbitrarily primed PCRTHIES, F. L; HARTUNG, H.-P; GIEGERICH, G et al.FEMS microbiology letters. 1998, Vol 165, Num 2, pp 329-334, issn 0378-1097Article

Inhibition of cytokine-inducible nitric oxide synthase in rat microglia and murine macrophages by methyl-2,5-dihydroxycinnamateZIELASEK, J; MÜLLER, B; HARTUNG, H.-P et al.Neurochemistry international. 1996, Vol 29, Num 1, pp 83-88, issn 0197-0186, 5 p.Article